BSE filing, BSE: 543916. Summary written from the filing by ALFA Finder's alert engine.
Hemant Surgical Industries Ltd: key numbers
- Share price
- ₹572.55
- Market cap
- ₹746.5 Cr
- Revenue (annual)
- ₹231.8 Cr
- Net profit (annual)
- ₹18.19 Cr
- P/E (TTM)
- 41.0×Sector 52.0×
- Promoter holding
- 52.83%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hemant Surgical Industries Ltd
All →Hemant Surgical Industries Other Announcement
Hemant Surgical Industries Ltd filed its quarterly shareholding pattern statement for the period ended September 30, 2026, as required under SEBI regulations.
Hemant Surgical Industries Annual General Meeting
Hemant Surgical Industries Ltd. conducted its 37th Annual General Meeting on September 29, 2026. Shareholders adopted financial statements and ratified the Cost Auditor's remuneration.
Hemant Surgical Industries Annual Report
Hemant Surgical Industries Ltd has filed its Integrated Annual Report and Notice of the 37th Annual General Meeting for the financial year 2025-26.
Hemant Surgical Industries Annual General Meeting
Hemant Surgical Industries Ltd has scheduled its 37th Annual General Meeting for September 29, 2026, to be conducted through video conferencing.
Hemant Surgical Industries Board Meeting Outcome
Hemant Surgical Industries approved its Directors' Report and Management Discussion and Analysis for FY2026, and scheduled its 37th Annual General Meeting for September 29, 2026.
Hemant Surgical Industries Announces New Order Win
Hemant Surgical Industries signed a manufacturing agreement with Sonomed Escalon, USA for ophthalmic ultrasound devices. The deal establishes local SKD manufacturing and exclusive distribution rights within India.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.